GeoVax Labs, Inc.

GeoVax Labs, Inc.verified

GOVX

Price:

$2.21

Market Cap:

$20.85M

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Preve...[Read more]

Industry

Biotechnology

IPO Date

2020-09-25

Stock Exchange

NASDAQ

Ticker

GOVX

The PE Ratio as of December 2024 (TTM) for GeoVax Labs, Inc. (GOVX) is -0.26

According to GeoVax Labs, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.26. This represents a change of -40.26% compared to the average of -0.44 of the last 4 quarters.

GeoVax Labs, Inc. (GOVX) Historical PE Ratio (quarterly & annually)

How has GOVX PE Ratio performed in the past?

The mean historical PE Ratio of GeoVax Labs, Inc. over the last ten years is -6665.73. The current -0.26 PE Ratio has changed -99.61% with respect to the historical average. Over the past ten years (40 quarters), GOVX's PE Ratio was at its highest in in the March 2024 quarter at -0.21. The PE Ratio was at its lowest in in the September 2016 quarter at -18876.73.

Quarterly (TTM)
Annual

Average

-6665.73

Median

-5452.83

Minimum

-16151.01

Maximum

-0.53

GeoVax Labs, Inc. (GOVX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of GeoVax Labs, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.76%

Maximum Annual PE Ratio = -0.53

Minimum Annual Increase = -98.59%

Minimum Annual PE Ratio = -16151.01

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.53-69.05%
2022-1.71-76.99%
2021-7.44-83.02%
2020-43.82-77.23%
2019-192.49-98.59%
2018-13691.53-15.23%
2017-16151.0150.76%
2016-10713.18-17.80%
2015-13033.311.65%
2014-12822.25-16.41%

GeoVax Labs, Inc. (GOVX) Average PE Ratio

How has GOVX PE Ratio performed in the past?

The current PE Ratio of GeoVax Labs, Inc. (GOVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.23

5-year avg

-49.20

10-year avg

-6665.73

GeoVax Labs, Inc. (GOVX) PE Ratio vs. Peers

How is GOVX’s PE Ratio compared to its peers?

GeoVax Labs, Inc.’s PE Ratio is less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Virios Therapeutics, Inc. (-0.76), greater than Zura Bio Limited (-4.88), less than Navidea Biopharmaceuticals, Inc. (0.00), less than ZyVersa Therapeutics, Inc. (-0.00), greater than Phio Pharmaceuticals Corp. (-0.30), less than Sonnet BioTherapeutics Holdings, Inc. (-0.18), greater than 180 Life Sciences Corp. (-0.59), greater than Cardio Diagnostics Holdings, Inc. (-3.05), greater than Kiromic BioPharma, Inc. (-1.13), less than Apexigen, Inc. (-0.24), less than Altamira Therapeutics Ltd. (-0.02), less than Avenue Therapeutics, Inc. (-0.21), greater than Quoin Pharmaceuticals, Ltd. (-0.30), less than Blue Water Vaccines, Inc. (-0.01), less than PaxMedica, Inc. Common Stock (-0.03), less than Revelation Biosciences, Inc. (-0.05), greater than Hillstream BioPharma, Inc. (-0.99), less than Jaguar Health, Inc. (-0.24), less than Onconova Therapeutics, Inc. (-0.09), greater than iBio, Inc. (-0.88), greater than Ocugen, Inc. (-4.33),

Build a custom stock screener for GeoVax Labs, Inc. (GOVX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeoVax Labs, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GeoVax Labs, Inc. (GOVX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GeoVax Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is GeoVax Labs, Inc.'s PE Ratio?

How is the PE Ratio calculated for GeoVax Labs, Inc. (GOVX)?

What is the highest PE Ratio for GeoVax Labs, Inc. (GOVX)?

What is the 3-year average PE Ratio for GeoVax Labs, Inc. (GOVX)?

What is the 5-year average PE Ratio for GeoVax Labs, Inc. (GOVX)?

How does the current PE Ratio for GeoVax Labs, Inc. (GOVX) compare to its historical average?